Human Rights Violations Impede Progress in Ending AIDS Pandemic
On World AIDS Day 2023, sixteen celebrities supported UNAIDS' call for world leaders to prioritize human rights to end AIDS, highlighting that 1.3 million people were newly infected with HIV in 2023—three times higher than the global target—due to widespread human rights violations, especially again...
Human Rights Violations Impede Progress in Ending AIDS Pandemic
On World AIDS Day 2023, sixteen celebrities supported UNAIDS' call for world leaders to prioritize human rights to end AIDS, highlighting that 1.3 million people were newly infected with HIV in 2023—three times higher than the global target—due to widespread human rights violations, especially again...
Progress
44% Bias Score
Rwanda's HIV/AIDS Progress: Celebrating Milestones, Addressing Persistent Challenges
Rwanda celebrates progress in its HIV/AIDS fight, achieving UNAIDS "Triple 95" targets, yet faces challenges like stigma and risky youth behaviors, requiring continued efforts to end AIDS by 2030.
Rwanda's HIV/AIDS Progress: Celebrating Milestones, Addressing Persistent Challenges
Rwanda celebrates progress in its HIV/AIDS fight, achieving UNAIDS "Triple 95" targets, yet faces challenges like stigma and risky youth behaviors, requiring continued efforts to end AIDS by 2030.
Progress
24% Bias Score
Unexpected HIV Diagnosis in India Highlights Testing Gaps and Stigma
A 38-year-old Austrian man, Christopher Klettermayer, discovered his HIV-positive status unexpectedly during a mandatory test at an Indian ashram in 2014, after months of undiagnosed illness in Austria, prompting a personal journey of acceptance and advocacy against the stigma surrounding the virus.
Unexpected HIV Diagnosis in India Highlights Testing Gaps and Stigma
A 38-year-old Austrian man, Christopher Klettermayer, discovered his HIV-positive status unexpectedly during a mandatory test at an Indian ashram in 2014, after months of undiagnosed illness in Austria, prompting a personal journey of acceptance and advocacy against the stigma surrounding the virus.
Progress
28% Bias Score
Lenacapavir: A Highly Effective but Expensive HIV Drug
Lenacapavir, a new HIV drug from Gilead, offers near-100% efficacy with twice-yearly injections but faces accessibility challenges due to its $40,000 annual cost, although Gilead is negotiating lower prices in 120 low-income countries.
Lenacapavir: A Highly Effective but Expensive HIV Drug
Lenacapavir, a new HIV drug from Gilead, offers near-100% efficacy with twice-yearly injections but faces accessibility challenges due to its $40,000 annual cost, although Gilead is negotiating lower prices in 120 low-income countries.
Progress
60% Bias Score
Rise in European HIV Diagnoses in 2023
A new report reveals a 2.4% increase in new HIV diagnoses across 47 European countries in 2023, reaching 113,000 cases, despite a global decline; increased testing is cited as a contributing factor, yet around 30% of those with HIV remain undiagnosed.
Rise in European HIV Diagnoses in 2023
A new report reveals a 2.4% increase in new HIV diagnoses across 47 European countries in 2023, reaching 113,000 cases, despite a global decline; increased testing is cited as a contributing factor, yet around 30% of those with HIV remain undiagnosed.
Progress
20% Bias Score
Living with HIV: Personal accounts reveal emotional and social challenges
Five individuals share their experiences of living with HIV in France and Switzerland, highlighting the emotional challenges of diagnosis, the evolving understanding of the disease, and the persistent stigma surrounding it.
Living with HIV: Personal accounts reveal emotional and social challenges
Five individuals share their experiences of living with HIV in France and Switzerland, highlighting the emotional challenges of diagnosis, the evolving understanding of the disease, and the persistent stigma surrounding it.
Progress
28% Bias Score
Beni, DRC: HIV/AIDS Treatment Successes and Challenges
In Beni, Democratic Republic of Congo, two women, Esther Kavugho and Désanges Malikidogo, living with HIV for over 20 years, share their positive experiences with free antiretroviral treatment and peer support groups, while highlighting challenges caused by religious beliefs that discourage medical ...
Beni, DRC: HIV/AIDS Treatment Successes and Challenges
In Beni, Democratic Republic of Congo, two women, Esther Kavugho and Désanges Malikidogo, living with HIV for over 20 years, share their positive experiences with free antiretroviral treatment and peer support groups, while highlighting challenges caused by religious beliefs that discourage medical ...
Progress
40% Bias Score
HIV Stigma and Discrimination Hinder Progress Despite Treatment Advancements
While HIV is now a manageable chronic illness, stigma and discrimination persist, impacting quality of life and access to care; studies in Greece and Cyprus reveal high levels of misinformation and prejudice, highlighting the need for targeted public awareness campaigns and policy changes.
HIV Stigma and Discrimination Hinder Progress Despite Treatment Advancements
While HIV is now a manageable chronic illness, stigma and discrimination persist, impacting quality of life and access to care; studies in Greece and Cyprus reveal high levels of misinformation and prejudice, highlighting the need for targeted public awareness campaigns and policy changes.
Progress
20% Bias Score
Magic Johnson's 1991 HIV Announcement: A Turning Point in AIDS Awareness
On November 7, 1991, NBA star Earvin "Magic" Johnson publicly revealed his HIV-positive status, shattering societal stigmas and increasing HIV testing rates, particularly among heterosexual Black and Latino men in the US.
Magic Johnson's 1991 HIV Announcement: A Turning Point in AIDS Awareness
On November 7, 1991, NBA star Earvin "Magic" Johnson publicly revealed his HIV-positive status, shattering societal stigmas and increasing HIV testing rates, particularly among heterosexual Black and Latino men in the US.
Progress
40% Bias Score
French Guiana's HIV Crisis: A Culture of Silence and Geographical Barriers
French Guiana has seven times the national average of HIV infections, mainly affecting heterosexuals and linked to poverty, limited healthcare access, and common multiple sexual partners; a local NGO, Aides, combats this through awareness campaigns and support.
French Guiana's HIV Crisis: A Culture of Silence and Geographical Barriers
French Guiana has seven times the national average of HIV infections, mainly affecting heterosexuals and linked to poverty, limited healthcare access, and common multiple sexual partners; a local NGO, Aides, combats this through awareness campaigns and support.
Progress
16% Bias Score
HIV Diagnoses Rise in Europe in 2023
In 2023, 113,000 new HIV diagnoses were reported across 47 European countries—a 2.4% increase from 2022, with eight countries reporting their highest annual case count in a decade, highlighting challenges in prevention and late diagnoses.
HIV Diagnoses Rise in Europe in 2023
In 2023, 113,000 new HIV diagnoses were reported across 47 European countries—a 2.4% increase from 2022, with eight countries reporting their highest annual case count in a decade, highlighting challenges in prevention and late diagnoses.
Progress
28% Bias Score
Semiannual HIV Injection Shows High Efficacy, Poses Access Challenges
A Phase 3 trial shows Lenacapavir, a semiannual HIV prevention injection, is highly effective and comparable to daily Truvada, offering improved adherence and reducing stigma in high-prevalence regions, but its high cost poses a global access challenge.
Semiannual HIV Injection Shows High Efficacy, Poses Access Challenges
A Phase 3 trial shows Lenacapavir, a semiannual HIV prevention injection, is highly effective and comparable to daily Truvada, offering improved adherence and reducing stigma in high-prevalence regions, but its high cost poses a global access challenge.
Progress
40% Bias Score